Roux-en-Y gastric bypass (RYGB) has become a prominent therapeutic option for long-term treatment of morbid obesity and type 2 diabetes mellitus (T2D). Cross talk and pathogenetic consequences of RYGB-induced profound effects on metabolism and gut microbiome are poorly understood. The aim of the present study therefore was to characterize intra-individual changes of gut microbial composition before and 3 months after RYGB by metagenomic sequencing in morbidly obese patients (body mass index (BMI)440 kg m À 2 ) with T2D. Subsequently, metagenomic data were correlated with clinical indices. Based on gene relative abundance profile, 1061 species, 729 genera, 44 phyla and 5127 KO (KEGG Orthology) were identified. Despite high diversity, bacteria could mostly be assigned to seven bacterial divisions. The overall metagenomic RYGB-induced shift was characterized by a reduction of Firmicutes and Bacteroidetes and an increase of Proteobacteria. Twenty-two microbial species and 11 genera were significantly altered by RYGB. Using principal component analysis, highly correlated species were assembled into two common components. Component 1 consisted of species that were mainly associated with BMI and C-reactive protein. This component was characterized by increased numbers of Proteobacterium Enterobacter cancerogenus and decreased Firmicutes Faecalibacterium prausnitzii and Coprococcus comes. Functional analysis of carbohydrate metabolism by KO revealed significant effects in 13 KOs assigned to phosphotransferase system. Spearmen's Rank correlation indicated an association of 10 species with plasma total-or low-density lipoprotein cholesterol, and 5 species with triglycerides. F. prausnitzii was directly correlated to fasting blood glucose. This is the first clinical demonstration of a profound and specific intra-individual modification of gut microbial composition by full metagenomic sequencing. A clear correlation exists of microbiome composition and gene function with an improvement in metabolic and inflammatory parameters. This will allow to develop new diagnostic and therapeutic strategies based on metagenomic sequencing of the human gut microbiome.
INTRODUCTION
Increasing evidence indicates that gut microorganisms may have a critical role in determining obesity in addition to hypercaloric diet and physical inactivity against an unfavourable genetic background. Several mechanisms have been predicted through which intestinal microorganisms may facilitate weight gain and fat accumulation. Thus, intestinal microorganisms could be contributing to obesity by increasing recovery of energy from the diet 1 and via the impact of microbial metabolites or microbial cell-derived signals on host pathways that regulate energy homoeostasis and lipid metabolism. 1 Several gut microbial diversity surveys in mouse models 2 and humans 3, 4 provided evidence that obesity was associated with a decreased proportion of Bacteroidetes and a higher proportion of Firmicutes. Subsequent functional analysis revealed that the obese human gut microbiome was enriched for phosphotransferase systems involved in microbial processing of carbohydrates primarily present in Actinobacteria and Firmicutes. 4 In contrast to these data, Schwiertz et al. 5 demonstrated in a study on human volunteers an altered composition of gut microbiota in favour of Bacteroidetes in overweight and obese subjects with a concomitant reduction of Firmicutes. These changes were associated with an increased faecal amount of short-chain fatty acids in general and propionate in obese individuals in particular, which may serve as a precursor for gluconeogenesis and liponeogenesis in liver metabolism. correlated positively and significantly with plasma glucose concentration but not with body mass index (BMI). 6 Beyond metabolic microbiota-host cross talk, proposed mechanisms for the role of gut microbiota in diabetes also include an increased intestinal permeability causing elevated systemic levels of lipopolysaccharides promoting insulin resistance and hyperinsulinemia. 7 In some studies, modification of gut microbiota induced by antibiotics or prebiotics resulted in a reduced inflammatory activity accompanied by a recovery of insulin sensitivity and decreased obesity. 7 Bariatric surgery has become a prominent therapeutic option to treat morbid obesity. Roux-en-Y gastric bypass (RYGB) is the major bariatric intervention that is associated with striking weight reduction, impressive improvements of glycemic control and inflammatory status in diabetic patients. 8, 9 However, so far the mechanisms of these profound changes remain largely unexplored. Detailed studies are necessary to link both the preoperative metabolic state and the postoperative changes to gut microbiota composition. There are only very few studies addressing the host metabolic-microbial cross talk after RYBG. In a study on a non-obese rat model, RYGB resulted in decreased amounts of Firmicutes and Bacteroidetes but a 52-fold higher concentration of Proteobacteria in comparison with shamoperated rats. 10 In a preliminary study on humans, Zhang et al.
11 demonstrated a significant reduction of Firmicutes in post-gastric-bypass individuals, who had concomitantly a proportional increase of Gammaproteobacteria. Based on a realtime quantitative PCR profiling of gut microbiota in faecal samples, Furet et al. 12 found an increase in the Bacteroides/ Prevotella group 3 months after RYGB, which was lower preoperatively in obese subjects relative to lean controls. In the same study, lactic acid bacteria including Lactobacillus/ Leuconostoc/Pediococcus group and Bifidobacterium genus decreased 3 months after RYGB. 12 Regarding diabetes and inflammatory state, the butyrate-producing species F. prausnitzii was found to be negatively associated with inflammatory markers before RYGB and throughout the postoperative period, indicating its contribution to a healthy intestine independently of changes in food intake. 12 Metagenomic sequencing is a powerful tool for a complete qualitative and quantitative analysis of the gut microbiome, including microbial species of very low abundance. By applying it to the human gut, 3.3 million nonredundant microbial genes from faecal samples of 124 European individuals have been identified. 13 The objective of this study was a comprehensive characterization by metagenomic sequencing of faecal microbiota composition in morbidly obese individuals with type 2 diabetes before and 3 months after RYGB in order to determine significant changes of high-and low-abundance microbial species. In this pilot study of six patients, we identified 22 microbial species from the complete metagenome, consisting of 1061 species, which were significantly affected by RYGB and may be associated with postoperative metabolic changes.
MATERIALS AND METHODS

Patient background
Six patients for Roux-en-Y gastric-bypass operation were recruited according to the S3 guidelines of the German Society for Obesity (ed. June 2010) in the Dresden Interdisciplinary Adiposity Centre at the Department of Internal Medicine of the Community Hospital DresdenNeustadt. Morbidly obese patients were evaluated for bariatric surgery by an interdisciplinary team and were included in the study if they fulfilled the criteria for bariatric surgery (BMI 440 kg m À 2 with comorbidity, age below 60 years, 2 years of unsuccessful conservative treatment and approval of surgery by their health insurance). Each patient provided written informed consent and the study was approved by the Dresden Ethics Committee (EK280082011) in accordance with the Declaration of Helsinki principles.
A total of six morbidly obese patients (three men and three women; BMI440 kg m À 2 ) were investigated before and 3 months after Roux-en-Y gastric-bypass surgery. Five of these patients (two men and three women) had manifest type 2 diabetes mellitus (T2D). Five of the patients had not received any antibiotics for at least 3 months before sampling and during observation period. One patient (number 5) received penicillin for 6 days owing to tonsillitis 3 weeks before the postoperative sample has taken. Basal anthropometric and clinical data are presented in Table 1 .
Blood samples for clinical chemistry and hormonal profile were taken after overnight fast. Ethylenediaminetetraacetic acid-plasma and serum were prepared by 10-min centrifugation at 4 1C and 3000 g. All samples were immediately frozen and stored at À 80 1C until analysed.
Clinical chemistry indices
Plasma triglycerides, total cholesterol, high-density lipoprotein and lowdensity lipoprotein (LDL) cholesterol were determined by standard enzymatic methods on a MODULAR analyser (Roche, Indianapolis, IN, USA), free fatty acid on a COBAS MIRA analyser (Global Medical Instrumentation, Ramsey, MN, USA) and plasma glucose on a DX80 analyser (Beckman-Coulter, Fullerton, CA, USA). HbA 1c was measured by high-performance liquid chromatography (Bio-Rad Laboratories, Richmond, CA, USA).
Gastric-bypass surgery
Gastric-bypass surgery by RYGB included the creation of a small stomach pouch using a stapler device, and its connection to the distal small intestine. The upper part of the small intestine was then reattached in a Y-shaped configuration. The stomach pouch is too small to hold large amounts of food, and by skipping the duodenum, fat absorption is substantially reduced.
Human faecal sample collection and DNA isolation Faecal samples were collected by paper-based stool collectors (Suess, Gudensberg, Germany) and transferred into sterile tubes with sterile screw caps (Sarstedt, Nü mbrecht, Germany). Until analysis, samples were kept at À 80 1C. For DNA isolation, a frozen aliquot (200 mg) of each faecal sample was suspended in 250 ml of guanidine thiocyanate, 0.1 M Tris (pH 7.5) and 40 ml of 10% N-lauroyl sarcosine. Mechanical cell disruption was performed using a Retsch mixer mill MM400 (Retsch, Haan, Germany) with glass beads. Then, DNA extraction was performed as previously described. 14 The DNA concentration and its molecular size were estimated by Nanodrop (Thermo Scientific, San Diego, CA, USA) and agarose gel electrophoresis.
DNA library construction and sequencing DNA library construction was performed following the manufacturer's instruction (Illumina, Wilmington, DE, USA). We used the standard workflow as described elsewhere to perform cluster generation, template hybridization, isothermal amplification, linearization, blocking and denaturalization, and hybridization of the sequencing primers.
We constructed one paired-end (PE) library with insert size of 350 bp for each sample (the actual insert size ranged from 321 to 343 bp), followed by high-throughput sequencing to obtain B15 million PE reads. The reads length for each end was 100 bp. Through filtering low-quality reads containing 'N' base, adaptor contamination reads and human host DNA contamination reads, we obtained the highquality reads.
Computation of relative abundance
High-quality reads of each sample were mapped to the human gut gene catalogue 13 using SOAP2 15 with the criterion of identity X 90%. When we translated the aligned results to the gene relative abundance, only two types of mapping results were considered: (a) a PE read should be mapped onto a gene with the correct insert-size relationship; (b) one end of the PE reads should be mapped onto the end of a gene with assuming the other end of read was mapped outside the gene region. In both cases, the mapped read was only counted as one copy.
Then, for any sample S the relative abundance was calculated as follows:
Step 1: calculate the copy number of each gene:
Step 2: calculate the relative abundance of gene i
where a i is the relative abundance of gene i in sample S, L i is the length of gene i, x i is the times that gene i can be detected in sample S (the number of mapped reads) and b i is the copy number of gene i in the sequenced data from sample S.
Based upon human gut gene catalogue's annotation information, genes can be assigned to different taxonomy levels and KEGG Orthologues (KOs). For species profile, corresponding gene abundances of the same species were summed. This gross relative abundance was taken as this species' relative abundance. The genus, phylum and KO relative abundance were constructed using the same method used for species. For further analysis, each profile must be normalized to the column sum of each profile.
Statistic test analysis
All statistical analyses were performed with the SPSS statistical package (v.18.0 for Windows; SPSS, Chicago, IL, USA). For comparisons between preand postoperative abundances at species and genera level, an univariate analysis of variance was performed. These results were confirmed using a nonparametric Kolmogorov-Smirnov test.
In order to assemble highly correlated species into common factors and thereby to obtain a multivariate preliminary data survey, a 'Principal Component Analysis' of all 22 previously identified microbial species was performed. Using 'Eigenvalues' over 2.5 and 'Varimax' rotation with Kaiser Normalization, two factors (components) were extracted. Factor composition and factor loadings are shown in Table 4 . Subsequent multivariate analysis was realized with component 1 and 2 as dependent variables, status before and after bypass as independent factor, and BMI as covariate. Consecutively, a univariate analysis with P-values corrected for multiple testing (Bonferroni procedure) was used to identify RYGB-induced differences for components 1 and 2.
Spearman rank correlation tests were applied to evaluate the correlation between species abundances and BMI or C-reactive protein (CRP). In addition, a partial correlation analysis with BMI as cofactor has been performed to test an independent association of CRP with relative species abundances.
Data in Tables 3 and 4 are given as means±s.e.m. A value of Po0.05 was considered statistically significant.
RESULTS
Clinical characteristics of the study population According to the guidelines for bariatric surgery, three men and three women, age 38-53 years, preoperative BMI 40.9-52.1 kg m À 2 , were recruited for RYGB (Table 1 ). All three women and two of the men were diagnosed having T2D for 1.5-22 years. Patient no.1 with long-lasting T2D was preoperatively treated with insulin, all remaining patients with metformin. Glycemic control based on preoperative fasting values of blood glucose and HbA 1c revealed that four of the T2D patients were treated adequately (HbA 1c p6.7%), one patient (no.4) was chronically hyperglycemic (HbA 1c ¼ 9.0; Table 1 ). Preoperatively, all six patients were hypertensive, four had hypertriglyceridemia, and five had elevated total cholesterol (Table 1) .
Three months after RYGB, BMI was decreased by 15-32% in all patients (Table 1 ). There was a concurrent reduction in systolic (by 10-55 mmHg) and in 5 of 6 cases of diastolic blood pressure (Table 1) . Changes in plasma lipid profile were characterized by reduction of triglycerides (5 from 6 cases), total-and LDLcholesterol (all cases). Plasma high-density lipoprotein cholesterol increased in two of six cases (Table 1) . Postoperative reduction of HbA 1c mainly depended on baseline values and ranged between 1.8 and 0.1%. Four of six patients revealed changes in HbA 1c lower than 0.2%, indicating a stable metabolic situation before surgery (Table 1) . 
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Based on clinical chemistry data, the preoperative situation was characterized by high-normal CRP values (2.1-5.6 mg l À 1 ) in all patients, indicating a latent activated general inflammation, partially increased liver enzymes (patients 2, 3 and 4) and a tendency of higher uric acid levels in all patients (Supplementary Table A) . Three months after bariatric surgery, CRP values decreased in five of six patients (except patient 4). All patients had lower postoperative plasma values for g-glutamyltransferase and uric acid. In five of six patients, reduced plasma concentration were observed for ALAT (except patient 3) and total serum protein (except patient 4). Plasma concentrations of transferrin mostly remained within the preoperative range (Supplementary Table A) .
Taken together, these data confirm that the acute loss of body weight is associated with a significant improvement of the metabolic situation, including glucose and lipid metabolism, a marked reduction of blood pressure and an attenuated overall inflammatory state, which is regarded as an indicator for cardiovascular risk.
Metagenomics sequencing of gut microbial community Twelve faecal specimens from six patients were collected, both before and 3 months after surgery. Total DNA was extracted from the faecal specimens and an average of 3.6 Gb (ranging from 3.1 to 4.1 Gb) of sequencing data was generated for each sample. After removing the human contamination reads and low-quality reads, the remaining reads rate is between 92.91 and 99.61 and 96.55% on average, allowing us to capture most of the repertoire of the gut microbial flora.
In order to obtain the gene relative abundance profiling, all reads were mapped individually to the human gut microbial gene catalogue from the faecal samples of 124 adult Europeans, MetaHIT project, by SOAP2. 13 The mapping rate ranges from 55.03 to 70.91% (on average 63.62%), which was comparable to the mapping rate of our own sample used for constructing the gene set, suggesting the reference catalogue has a sufficient coverage for the severely obese samples in this study.
Based on the gene relative abundance, profile phylum, genus and species profiles were acquired. There were 45.21%, 58.89%, 72.72% and 47.03% of the human gut genes that have species, genus, phylum and kegg function annotation information, respectively. Finally, 1061 species, 729 genera, 44 phyla and 5127 KOs were subjected to the further analysis.
Taxonomy composition of the samples To simplify the comparison, only those phyla with average abundance 40.1% in at least one group are displayed in Figure 1 . Although bacteria in the human intestinal community are highly diverse, they fell mainly into seven bacterial divisions, of which Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria and Verrucomicrobia were the most abundant phyla in the human gut intestinal. 16 Four of the top seven high abundance phyla were decreased in postoperative samples, including Firmicutes (from 47.2 to 34.2%), Bacteroidetes (from 46.9 to 44.7%), Actinobacteria (from 1.7 to 1.2%) and Cyanobacteria (from 0.10 to 0.06%) (Figure 1) . However, the ratios of Bacteroidetes/Firmicutes shifted from 0.99 to 1.31, showing an apparent increase. Three other phyla were increasing: Proteobacteria (from 2.68 to 13.74%), Verrucomicrobia (from 0.65 to 5.37%) and Fusobacteria (from 0.19 to 0.23%) (Figure 1) .
At species taxonomy level of the 31 high-abundance species (with average abundance 41% in at least one group), Akkermansia muciniphila, Escherichia coli and Klebsiella pneumonia showed a clear tendency of increase (Supplementary Figure A) . On the other hand, F. prausnitzii, Eubacterium rectale and Dialister invisus revealed a strong tendency to decrease (Supplementary Figure A) . The RYGB-induced changes at species level were consistent with changes at genus level, where relative abundances of Faecalibacterium and Eubacterium decreased and those of Akkermansia and Escherichia postoperatively increased (Supplementary Figure B) .
Effect of RYGB on gut microbiome Univariate analysis of variance was used to identify significant differences in relative abundances of microbial species, genera and phyla between pre-and postoperative samples. Significant differences could be established for 22 microbial species, 11 genera and 1 phylum. These results have been confirmed by a nonparametric Kolmogorov-Smirnov test. As shown in Table 2 , 3 months after RYGB, relative abundances increased significantly for E. cancerogenus (by 1992%, P ¼ 0.002), Veillonella parvula (by 184%, P ¼ 0.035), V. dispar (by 532%, P ¼ 0.038), Shigella boydii (by 4649%, P ¼ 0.039) and Salmonella enterica (by 652%, P ¼ 0.043). It is of high interest that postoperative abundances of these species were also significantly higher than those in lean controls (Table 2) . These changes appear to reflect profound changes in the milieu interior of the gut rather than decrease in body weight.
At the same time, relative abundances decreased in 17 species, most pronounced in Treponema pallidum (by 87%, P ¼ 0.011), Mycobacterium kansasii (by 74%, P ¼ 0.011), F. prausnitzii (by 70%, P ¼ 0.013) and C. comes (by 58%, P ¼ 0.013) ( Table 2 ). Among the species that decreased significantly 3 months after gastric bypass were also two Lactobacilli species. Whereas postoperative abundances of Lactobacillus reuteri were significantly lower than in lean controls, L. acidophilus did not reveal any differences between pre-or postoperative values and lean controls.
Preoperative abundances of Clostridium spiroforme, Brachyspira hyodysenteriae and Fusobacterium periodonticum were significantly lower than in lean controls and continued to decrease postoperatively (Table 2) . Same general tendency could be observed for Anaerostipes caccae, F. periodonticum, Thermomicrobium roseum, Staphylococcus epidermidis and Fibrobacter succinogenes, which, however, did not show statistically significant lower preoperative values than controls, but reaching statistical significance after continued postoperative decline (Table 2) .
Univariate analysis of variance for selective species has been performed to identify significant RYGB effects on microbial genera (Table 3) . Among 12 genera, which were significantly affected, 5 genera increased postoperatively: Enterobacter, Neurospora, Citrobacter, Veillonella and Salmonella (Table 3) . Basically, with regard to Enterobacter, Veillonella and Salmonella, this is in Metagenomic analysis in RYGB-treated patients with diabetes J Graessler et al accordance with postoperatively increasing species. In addition, an augmentation of relative abundances of Neurospora and Citrobacter has been registered. Lacking indication for selective species of these genera may be caused by high interindividual variations and a low number of observations. The strong tendency of a postoperative increase of genus Shigella (P ¼ 0.056) was confirmed by an augmentation of the corresponding species S. boydii (Table 3) . However, seven genera decreased 3 months after RYGB, whereby five of them were in accordance with postoperative changes of selected species: Faecalibacterium, Coprococcus, Helicobacter, Anaerostipes and Nakamurella (Table 3) . Without reflecting changes in corresponding selective species, a RYGB-induced reduction of genera Dictyostelium and Epidinium has been found.
Including all 22 species, which were significantly affected by RYGB, a principal component analysis (PCA) was performed (Table 4) . Using eigenvalues over 2.5 and Varimax rotation with Kaiser normalization two factors (components) were extracted, explaining total variance by 63.0% (component 1: 35.4%; component 2: 27.6%). Component 1 included 11 species and was mainly determined by L. acidophilus bearing factor loading 0.920. Component 2 also combined 11 species with Leptospira interrogans as species of highest factor loading (Table 4) .
Subsequent multivariate analysis was performed with components 1 and 2 as dependent variables, status before and after bypass as independent factor and BMI as covariate. A significant and independent effect of operation status (Pillai's trace P ¼ 0.007) emerged, but not of BMI (Pillai's trace P ¼ 0.146). Subsequent univariate analysis with P-values corrected for multiple tests (Bonferroni procedure) indicated a significant RYGB-induced difference for component 2 (P ¼ 0.005), but not for component 1 (P ¼ 0.704). This led to the suggestion that component 1 might include a group of species that is primarily correlated with changes in BMI. A nonparametric Spearman rank correlation test was performed to characterize the relationship of selected microbial species and BMI. The results indicated that 8 of 11 species in component 1, but only 2 species of 11 in component 2, were significantly correlated to BMI (Table 4 ). This might explain the annulling effect of BMI as covariate in multivariate analysis. On the other hand, the majority of species in component 2 seem to be associated with BMI-independent effects of RYGB. The individual effects of gastric bypass on the shift of components 1 and 2 are shown in Figure 2 .
In addition to species composition, functional analysis of carbohydrate metabolism by relative abundances of KO has been performed. Thirteen KOs assigned to phosphotransferase system increased significantly 3 months after RYGB (Supplementary Table  B) . It could be suggested that reduced dietary intake may trigger an increased ability to assimilate substrate in order to compensate host nutritional and energetic requirements.
Also, in a further analysis by Spearman rank correlation, a possible association of inflammatory state (defined by CRP values) and RYGB-induced changes at microbial species level were tested. Interestingly, 7 of 11 species in component 1, but only 2 species of 11 in component 2, were significantly correlated to CRP (Table 4) . This indicates a close interrelationship between BMI, gut microbial composition and inflammatory state. As the Spearman rank correlation coefficient between BMI and CRP was r ¼ 0.860 (Po0.001), it became clear that the association between CRP and species abundances was mainly determined by postoperative BMI changes. This was confirmed by a partial correlation analysis with BMI as cofactor that completely abolished the independent CRP-species association.
A possible association between RYGB-induced effects on microbial composition and human metabolic indices in plasma has been investigated ( Figure 3) . In a Spearman rank correlation analysis, significant direct correlation with total-and/or LDLcholesterol levels on one hand was found for F. succinogenes, Table 2 . Relative abundances of microbial species, which were significantly affected 3 month after Roux-en-Y gastric-bypass surgery. Comparison with lean control subjects (BMI o25 kg m Abbreviations: ANOVA, analysis of variance; BMI, body mass index.
Metagenomic analysis in RYGB-treated patients with diabetes J Graessler et al Acinetobacter johnsonii, T. pallidum, T. roseum, C. spiroforme and A. caccae (Figure 3 ). On the other hand, E. cancerogenus, V. parvula and dispar, and S. enterica were inversely correlated with plasma total-and LDL-cholesterol ( Figure 3 ). As plasma concentration of total-and LDL-cholesterol decreased in all patients 3 months after RYGB, the slope of each correlation was determined by increase or decrease of postoperative species abundances. Nevertheless, these data indicate that relative abundances of 10 from 22 identified species were associated with plasma cholesterol levels. Further significant correlations have been found for plasma triglycerides with 5 species (A. johnsonii, T. pallidum, A. caccae, E. cancerogenus and Veillonella dispar), for plasma glucose with F. prausnitzii, and HbA 1c with T. roseum and V. parvula (Figure 3 ). Plasma high-density lipoprotein cholesterol was not correlated with any of the microbial species.
DISCUSSION
The dominant effects of RYGB 3 months after surgery comprised a marked reduction of BMI combined with a significant improvement of the metabolic situation in all six patients, alleviating type 2 diabetes and resulting in clearly reduced inflammatory activity.
On the basis of a metagenomic survey, this study compared the intra-individual pre-post-operative differences of six morbidly obese individuals and correlated modifications of the metagenome with parameters of the individual lipid and carbohydrate metabolism. Three months after RYGB, dramatic changes of the individual composition of gut microbiota, characterized by significant prepost-operative differences in 22 microbial species, 11 genera and 1 phylum were observed. The most striking results were a substantial shift of the main gut phyla towards higher relative abundances of Proteobacteria, specifically E. cancerogenus, and lower relative abundances of Firmicutes and Bacteroidetes. These results were in accordance with general findings coming from recent experimental and clinical studies. In a RYGB model on rats, Li et al.
10 demonstrated a 52-fold postoperative increase of Proteobacteria, Enterobacter hormaechei being the dominant species. Simultaneously, the concentrations of Firmicutes and Bacteroidetes decreased significantly. 10 Comparing three morbidly obese individuals 6 months after RYGB with non-operated obese individuals, Zhang et al.
11 observed a significant decrease of Firmicutes in post-gastric-bypass individuals, who had a proportional increase in Gammaproteobacteria. In contrast, based on a real-time quantitative PCR technology, Furet et al. reported an increase of Bacteroidetes 3 months after RYGB. Differences between these studies may be related to the low number of observations, different employed technologies or varying degrees of obesity of investigated individuals. A close interrelationship between obesity and gut microbial composition has been reported in many studies. 1, 17, 18 Analysis of the gut microbiome in twins revealed a lower proportion of Bacteroidetes and a higher proportion of Actinobacteria in obese compared with lean individuals but no significant difference in Firmicutes. 4 However, weight loss in humans was associated with a progressive increase in the representation of Bacteroidetes. 3 In this study, RYGB-induced reduction of body weight resulted in a simultaneous decrease of Bacteroidetes and Firmicutes by varying degrees. Consequently, the changes of both phyla were correlated inversely (Spearman's correlation coefficient: À 0.678; P ¼ 0.019) and the ratio of Bacteroidetes/Firmicutes increased, in accordance to the data of Turnbaugh et al. 4 The average proportion of Proteobacteria was significantly increased with a concomitant decrease of Firmicutes (Spearman's correlation coefficient: À 0.664; P ¼ 0.022). Thus the Proteobacteria/Firmicutes ratio increased significantly from 0.061 to 0.471 (P ¼ 0.030), which is in accordance with earlier published data. 11, 18 It is important to consider that the majority of species in Proteobacteria phylum represent facultative anaerobes, while Firmicutes are dominated by anaerobic bacteria. The increase in dissolved oxygen after RYGB surgery might result in increased facultative anaerobe populations and decreased anaerobic bacteria. 19 Apart from that, gastric acid secretion is reduced after gastric bypass, leading to an increase of the human colon pH. Based on in vitro studies, the growth of the Gram-negative Bacteroidetes was found to be sensitive to mildly acidic pH, while the growth of Gram-positive Firmicutes and high GC content Actinomycetes showed greater tolerance of mildly acidic pH. 20 The increased human gut pH also contributed to the different alteration tendency of these major phyla.
Among microbial species that were affected by RYGB nine belong to phylum Firmicutes, five to Proteobacteria, three to Spirochaetes, two to Actinobacteria and one each to Fusobacteria, Chloroflexi and Fibrobacteres. By principal component analysis, which was performed in order to assemble highly correlated species into common factors, two groups (components) have been derived comprising 11 species each. Determining species of group 1 were Firmicutes, including Lactobacilli acidophilus and reuteri, F. prausnitzii, C. comes and S. epidermidis, which decreased significantly during the postoperative period. Species composition of group 2 was more heterogeneous conjoining most notably Spirochaetes, Proteobacteria and Fusobacteria. It is of special interest that selective species of the most abundant phyla Firmicutes and Proteobacteria did not respond uniformly on RYGB. Thus, seven species of Firmicutes decreased, while two species, in particular, V. parvula and dispar, increased. On the other hand, among Proteobacteria, the relative abundances of E. cancerogenus, S. boydii and S. enterica increased, whereas those of A. johnsonii and Pseudomonas mendocina decreased. These data emphasize that the differential adaptation of human gut microbiota to RYGB cannot be sufficiently explained at the phylum level. Owing to the close interspecies cross talk it may be sometimes difficult to assign a pathophysiological role to a certain species. For example, in this study F. prausnitzii, as a member of the Firmicutes phylum, decreased significantly after RYGB. In parallel, a decrease of the CRP, as indicator of inflammation activity, has been registered. Consequently, a direct correlation between F. prausnitzii and CRP could be derived. This is, at first glance, in contrast to the data of Furet et al., 12 who established a negative association of F. prausnitzii with inflammatory markers. Closer inspection reveals that in our study F. prausnitzii was highly correlated (directly or indirectly) with 10 further species in PCA-derived component 1, among them E. cancerogenus, which increased highly significantly after RYGB. At the same time, the decrease of F. prausnitzii was accompanied by the decrease of other butyrate-producing species like C. comes and A. caccae, which might dissemble the true interaction. Among members of PCA-derived component 1, six significantly correlated with BMI as well as CRP. Partial correlation analysis with BMI as cofactor, however, indicated that there was no independent correlation of CRP with these species. In contrast, only two members of PCA-derived component 2, Veillonella dispar and T. roseum, correlated with BMI and CRP. It could be suggested that the majority of species in component 2 is modulated by specific RYGB changes in the gut with regard to pH, oxygen tension and substrate availability rather than changes in BMI.
Bariatric surgery, in particular RYGB, has become a prominent therapeutic option to address morbidly obese patients with T2D. Meta-analyses reported complete resolution of diabetes in over 80% of patients who had undergone gastric-bypass surgery. 21 Some studies reported normalization of glucose homeostasis in patients with type 2 diabetes long before a noticeable weight reduction was achieved. 22 This could not be confirmed in other studies. 23 Weight loss and/or altered bowel physiology bringing along altered secretion of gastrointestinal peptides might contribute to this effect on glucose metabolism. In particular, the postprandial response of the incretin glucagon-like peptide-1 has been observed to be significantly influenced by RYGB. 24 Alternatively, clinical and experimental studies have clearly demonstrated that RYGB induces weight loss by altering physiological regulation of energy balance and metabolic function. 10, 12, [25] [26] [27] Calorimetric measurements in a RYGB mice model revealed increased resting energy expenditure and postprandial thermogenesis as main causes for higher postoperative energy consumption. 27 Global metabolic changes in a non-obese rat model of RYGB were characterized by a decrease in faecal bile acids and a shift from protein degradation to putrefaction through decreased faecal tyrosine with concomitant increases in faecal putrescine and diaminoethane. 10 These data led to the suggestion that human gut microbiota and their cross talk with host metabolism may have an important role for the metabolic conversion in patients with T2D after RYGB. In this study, 10 of 22 differentially modified species correlated with plasma total-and LDL-cholesterol level, 5 with triglyceride level and two with HbA 1c level. These data provide evidence that metabolic changes may not be restricted to RYGB-induced malnutrition, but also a result of modified gut microbiota composition.
Undoubtedly, RYGB is currently the most effective treatment for morbid obese patients with type 2 diabetes. RYGB-induced metabolic and microbial modifications can contribute to weight loss, metabolic improvements and, finally, longer lifespan. However, the shift to Proteobacteria, in particular to E. cancerogenus, S. boydii and S. enterica, as well as the decline of butyrateproducing Firmicutes, like F. prausnitzii, C. comes and A. caccae, could have long-term effects on host health with the potential risk of bowel inflammation and colorectal carcinomas. Long-term studies of such microbiota-host metabolic cross talks may considerably improve our comprehension of pathogenetic processes in obesity and diabetes. Based on these findings, it will be of high interest to see if therapeutic interventions could be designed to create a healthy gut microbiome, modulating in a positive way the normal intestinal flora and a healthy metagenome-genome symbiosis. This may include well-designed modulations in short-chain fatty acids, prebiotics, probiotics, antibiotics and finally microbial transplantation. 28 
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